Benazepril Hydrochloride/Lercanidipine Hydrochloride

盐酸贝那普利/盐酸乐卡地平

Report date: 2022/09/09 15:11:00

Base Information

Drug NameBenazepril Hydrochloride/Lercanidipine Hydrochloride
Drug Alias NameLercanidipine Hydrochloride+Benazepril Hydrochloride盐酸贝那普利乐卡地平盐酸乐卡地平盐酸贝那普利Benazepril Hydrochloride+Lercanidipine Hydrochloride盐酸乐卡地平+盐酸贝那普利 +[10] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersAngiotensin-converting enzyme inhibitors
TargetsVoltage-gated calcium channelAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Benazepril HydrochlorideLercanidipine Hydrochloride
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A